Identification of A2A adenosine receptors in porcine coronary arteries by a novel A2A antagonist radioligand, [3H]SCH58261

被引：0
|
作者：
Belardinelli, L
Shryock, JC
Ruble, J
Monopoli, A
Ongini, E
Dennis, DM
Baker, SP
机构：
[1] UNIV FLORIDA,GAINESVILLE,FL
[2] SCHERING PLOUGH CORP,RES INST,MILAN,ITALY
来源：
CIRCULATION | 1996年 / 94卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：955 / 955
页数：1
相关论文
共 50 条
  • [31] SCH58261 the Selective Adenosine A2A Receptor Blocker Modulates Ischemia Reperfusion Injury Following Bilateral Carotid Occlusion: Role of Inflammatory Mediators
    Mohamed, R. A.
    Agha, A. M.
    Nassar, N. N.
    NEUROCHEMICAL RESEARCH, 2012, 37 (03) : 538 - 547
  • [32] Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonists
    Shah, Unmesh
    Lankin, Claire M.
    Boyle, Craig D.
    Chackalamannil, Samuel
    Greenlee, William J.
    Neustadt, Bernard R.
    Cohen-Williams, Mary E.
    Higgins, Guy A.
    Ng, Kwokei
    Varty, Geoffrey B.
    Zhang, Hongtao
    Lachowicz, Jean E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 4204 - 4209
  • [33] Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice
    Domenici, M. R.
    Scattoni, M. L.
    Martire, A.
    Lastoria, G.
    Potenza, R. L.
    Borioni, A.
    Venerosi, A.
    Calamandrei, G.
    Popoli, P.
    NEUROBIOLOGY OF DISEASE, 2007, 28 (02) : 197 - 205
  • [34] Adenosine A2A Receptor Antagonist Sch58261 Improves the Cognitive Function in Alzheimer's Disease Model Mice Through Activation of Nrf2 via an Autophagy-Dependent Pathway
    Sun, Yi
    Liu, Chao
    He, Ling
    ANTIOXIDANTS & REDOX SIGNALING, 2024,
  • [35] SCH58261, the antagonist of adenosine A2A receptor, alleviates cadmium-induced preeclampsia via sirtiun-1/hypoxia-inducible factor-1α pathway in rats
    Shen, W-T
    Huang, Y-J
    Zhang, Q.
    Lin, F.
    Wang, X.
    Ye, D-Y
    Huang, Y-P
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (21) : 10941 - 10953
  • [36] SCH 58261 (an adenosine A2A receptor antagonist) reduces, only at low doses, K+-evoked glutamate release in the striatum
    Pintor, A
    Quarta, D
    Pèzzola, A
    Reggio, R
    Popoli, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 421 (03) : 177 - 180
  • [37] SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum
    Wardas, J
    Pietraszek, M
    Dziedzicka-Wasylewska, M
    BRAIN RESEARCH, 2003, 977 (02) : 270 - 277
  • [38] Voltammetry as the First Method for Direct Determination of a Novel Antagonist of A2A Adenosine Receptors
    Tyszczuk-Rotko, Katarzyna
    Sztanke, Malgorzata
    Sasal, Agnieszka
    Sztanke, Krzysztof
    ELECTROANALYSIS, 2019, 31 (12) : 2480 - 2487
  • [39] The adenosine A (2A) receptor antagonist SCH58261 protects photoreceptors by inhibiting microglial activation and the inflammatory response
    Cheng, Yajia
    Cao, Peipei
    Geng, Chao
    Chu, Xiaoqi
    Li, Yuhao
    Cui, Jianlin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 112
  • [40] Regulation of A1 and A2A adenosine receptors and G-proteins by A2A selective antagonist treatment in coronary artery.
    Rekik, M
    Mustafa, JS
    FASEB JOURNAL, 2001, 15 (04): : A219 - A219
12345